Close
AI in Healthcare & Pharma Summit Boston 2026

Energy Resilient Cleanrooms Reducing Operational Risk

In the face of rising energy costs and increasing climate volatility, the pharmaceutical industry must rethink cleanroom design to balance the rigorous demands of sterile manufacturing with the need for enhanced energy resilience and sustainability.

Pharma Utility Redundancy Improving Business Continuity

Ensuring the continuous operation of critical utilities such as purified water, clean steam, and HVAC systems is paramount for pharmaceutical manufacturers, where any interruption can lead to significant batch losses and compromised patient safety.

Flexible Manufacturing Facilities Supporting Cell Therapies

The paradigm shift from blockbusters to personalized medicine necessitates a new generation of adaptable manufacturing environments that can rapidly scale to meet the unique demands of cell and gene therapies while maintaining strict GMP compliance.

Utility Digitization Strengthening Pharma Resilience

The modern pharmaceutical facility relies on a complex web of utilities that must remain operational at all times integrating digital monitoring and smart controls into these systems ensures that critical infrastructure remains robust, efficient, and capable of supporting continuous manufacturing.

Bluesight Aims Efficiency with Redesigned 340BCheck Platform

Bluesight has introduced a fully redesigned 340BCheck platform, describing it as a compliance command center created to support covered entities in maintaining compliance standards...

Biologics Formulation Challenges and Innovative Solutions

Large-molecule drugs represent the most advanced frontier of modern therapy, yet their physical complexity presents unique hurdles for manufacturers. Overcoming the inherent instability and delivery obstacles of these fragile compounds is essential for bringing the next generation of life-saving biopharmaceuticals to patients worldwide.

Novel Formulation Strategies Enhancing Drug Stability

Ensuring the integrity of pharmaceutical compounds from production to the point of care is a fundamental challenge for the industry. New approaches in molecular stabilization and chemical engineering are extending the lifespan of critical medications, preventing degradation in diverse environmental conditions and maintaining therapeutic potency.

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...